People | June 06, 2022
APhA appoints Ilisa Bernstein Interim CEO
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
This new fund is amongst the largest for the sector in India
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
The first-of-its-kind unique centre will increase access to preventive & primary care
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Subscribe To Our Newsletter & Stay Updated
